Home
Live Updates
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q1 2022 Results - Earnings Call Transcript : vimarsana.com
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q1 2022 Results - Earnings Call Transcript
Eiger BioPharmaceuticals, Inc. (NASDAQ:NASDAQ:EIGR) Q1 2022 Earnings Conference Call May 5, 2022 04:30 PM ET Company Participants Sarah Mathieson - Senior Vice President-Corporate Affairs...
Related Keywords
Hong Kong ,
United States ,
Philadelphia ,
Pennsylvania ,
Brazil ,
China ,
Canada ,
Russia ,
Toronto ,
Ontario ,
France ,
Ukraine ,
American ,
David Corey ,
Michael Higgins ,
Sarah Mathieson ,
Robert Hazlett ,
Eiger Onecare ,
Merck Millipore ,
Yigal Nochomovitz ,
Ashik Mubarack ,
Ashiq Mubarack ,
David Cory ,
Luke Herrmann ,
Maury Raycroft ,
Colin Hislop ,
Brian Skorney ,
Ingrid Choong ,
Eldon Mayer ,
Colleen Craig ,
Company Participants ,
Ladenburg Thalmann ,
National Institutes Of Health ,
Corporate Affairs At Eiger ,
Nasdaq ,
Eiger Biopharmaceuticals Inc ,
Progeria Research Foundation ,
Corporate Affairs ,
Clinical Development ,
Eiger Biopharmaceuticals ,
Conference Call May ,
Vice President Corporate ,
Chief Executive ,
Vice President Clinical ,
Eiger Biopharmaceuticals First Quarter ,
Business Update Conference ,
Senior Vice President ,
Sri Ryali ,
Chief Financial Officer ,
Chief Commercial Officer ,
Ingrid Choong Senior Vice President ,
Peginterferon Lambda ,
Rare Pediatric Disease ,
National Institutes ,
Progeria Research ,
Jordan Feld ,
Avexitide Phase ,
Chief Technical Officer ,
North American ,
Breakthrough Therapy Designation ,
Maybei Ll ,
vimarsana.com © 2020. All Rights Reserved.